Exploring new therapies for children with autism: “Do no harm” does not mean do not try
Author:
Affiliation:
1. Division of Hematology/Oncology University of Virginia Cancer Center, Charlottesville, Virginia, USA
2. Marcus Center for Cellular Cures at Duke Duke University School of Medicine, Durham, North Carolina, USA
Publisher
Oxford University Press (OUP)
Subject
Cell Biology,Developmental Biology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/sctm.20-0548
Reference10 articles.
1. Safety of allogeneic umbilical cord blood stem cells therapy in patients with severe cerebral palsy: a retrospective study;Feng;Stem Cells Int,2015
2. Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial;Nguyen;BMC Pediatr,2017
3. Umbilical cord blood cells and brain stroke injury;Peterson;J Clin Invest,2004
4. Autologous cord blood infusions are safe and feasible in young children with autism spectrum disorder: results of a single-center phase I open-label trial;Dawson;Stem Cells Translational Medicine,2017
5. Safety and observations from a placebo-controlled, crossover study to assess use of autologous umbilical cord blodd stem cells to improve symptoms in children with autism;Chez;Stem Cells Translational Medicine,2018
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Umbilical Cord Blood Hematopoietic Cells: From Biology to Hematopoietic Transplants and Cellular Therapies;Archives of Medical Research;2024-09
2. Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities;Stem Cell Research & Therapy;2024-08-26
3. Mesenchymal Stem Cells and Purinergic Signaling in Autism Spectrum Disorder: Bridging the Gap between Cell-Based Strategies and Neuro-Immune Modulation;Biomedicines;2024-06-13
4. Outcomes of autologous bone marrow mononuclear cell administration in the treatment of neurologic sequelae in children with spina bifida;Stem Cell Research & Therapy;2023-04-28
5. Stem cell-based therapy for human diseases;Signal Transduction and Targeted Therapy;2022-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3